EN
HI
Summary
As of 2 Sep, 2026, Piramal Pharma stock price is ₹213.2. During the trading session, the stock has moved between an intraday low of ₹210.50 and an intraday high of ₹216.12. Over the last 52 weeks, Piramal Pharma has traded between ₹132.30 and ₹220.36.
The stock has recorded a trading volume of 31,47,005 shares, with a market capitalization of ₹1331348130. Its Average Traded Price (ATP) is ₹213.48, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 223 @ ₹213.20.
Piramal Pharma has an upper circuit limit of ₹255.84 and a lower circuit limit of ₹170.56. The total value traded stands at ₹67.18 CR, and the delivery percentage for the day is 32.79%.
The stock is currently traded with a market lot size of 1. Piramal Pharma also offers a dividend yield of 0%.
Piramal Pharma share price chart
Piramal Pharma Share Key Metrics
Volume
31.47 L
Market Cap
28384.34 CR
LTQ@LTP
223@213.20
ATP
213.48
Var Margin
18.2 %
Circuit Range
170.56-255.84
Delivery %
32.79 %
Value
67.18 CR
ASM/GSM
No
Market Lot
1
Piramal Pharma Fundamentals
P/E Ratio
0
P/B Ratio
3.57
Div. Yield
0
Sector P/E
41.23
Sector P/B
3.52
Sec. Div. Yield
0.51
Piramal Pharma Resistance and Support
Pivot 213.27
Resistance
First Resistance
216.04
Second Resistance
218.89
Third Resistance
221.66
Support
First Support
210.42
Second Support
207.65
Third Support
204.8
Piramal Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 01 2026 | 215 | 213.19 | -0.56% | 216.11 | 210.5 |
| Mon Aug 31 2026 | 218.5 | 214.39 | -1.96% | 218.61 | 211.5 |
| Fri Aug 28 2026 | 215.39 | 218.67 | 1.74% | 220 | 214.61 |
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Acquisition
Piramal Pharma has completed the acquisition of an additional 40.67% equity stake in Yapan Bio Private Limited for approximately Rs.76 crores. This increases Piramal Pharma's shareholding in Yapan to 74.00%, making Yapan a subsidiary and enhancing its large molecule capabilities for vaccines and biologics.
Aug 18 2026 11:34:02
Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Piramal Pharma announced that Deutsche Bank AG, acting as the onshore security agent, has released 98,400,000 pledged equity shares, representing 7.39% of the company's total equity. This release reduces the total pledged shareholding to 10.54% of the company's equity.
Aug 18 2026 11:29:56
Read More
Piramal Pharma Management
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Maneesh Sharma | Company Secretary and Compliance Officer |
Piramal Pharma Similar Stocks
Sai Life Sciences Ltd.
1518.10
0.00 (0.00%)
Wockhardt Ltd.
1850.60
0.00 (0.00%)
Rubicon Research Ltd.
1822.20
0.00 (0.00%)
Neuland Laboratories Ltd.
23025.00
0.00 (0.00%)
Acutaas Chemicals Ltd.
3174.30
0.00 (0.00%)
Pfizer Ltd.
4665.90
0.00 (0.00%)
Granules India Ltd.
837.20
0.00 (0.00%)
Caplin Point Laboratories Ltd.
2711.20
0.00 (0.00%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 213.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 3.57. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 41.23 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 28384.34 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 220.36 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
